4//SEC Filing
SHREWSBURY STEPHEN B 4
Accession 0001209191-22-005453
CIK 0001445499other
Filed
Jan 27, 7:00 PM ET
Accepted
Jan 28, 5:06 PM ET
Size
5.5 KB
Accession
0001209191-22-005453
Insider Transaction Report
Form 4
SHREWSBURY STEPHEN B
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2022-01-26+30,000→ 30,000 totalExercise: $9.85Exp: 2032-01-25→ Common Stock (30,000 underlying)
Footnotes (1)
- [F1]The option vests as to 2.0833% of the total shares on February 26, 2022 and then 2.0833% of the total shares vests monthly thereafter, with 100% of the total shares vested and exercisable on January 26, 2026, subject to the reporting person's provision of service to the issuer on each vesting date.
Documents
Issuer
IMPEL NEUROPHARMA INC
CIK 0001445499
Entity typeother
Related Parties
1- filerCIK 0001413821
Filing Metadata
- Form type
- 4
- Filed
- Jan 27, 7:00 PM ET
- Accepted
- Jan 28, 5:06 PM ET
- Size
- 5.5 KB